Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid Arthritis

NCT00579878 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Leflunomide
DRUG: Methotrexate-Sulfasalazine-Hydroxychloroquine
DRUG: Leflunomide-Sulfasalazine-Hydroxychloroquine

Sponsor

University of Nebraska